Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2014

Open Access 01-12-2014 | Oral presentation

Digital breast tomosynthesis improves the accuracy of the diagnosis of circumscribed lesions because of increase of margin visibility

Authors: R Wasan, J Morel, A Iqbal, D Evans, J Goligher, C Peacock, R Rahim, K Satchithananda, M Michell

Published in: Breast Cancer Research | Special Issue 1/2014

Login to get access

Excerpt

Circumscribed masses are a common cause of recall for assessment but most are benign. The aim of this study is to compare the accuracy of digital breast tomosynthesis (DBT) with digital mammography (DM) in assessing the margin of circumscribed lesions as a predictor of benign or malignant disease. …
Metadata
Title
Digital breast tomosynthesis improves the accuracy of the diagnosis of circumscribed lesions because of increase of margin visibility
Authors
R Wasan
J Morel
A Iqbal
D Evans
J Goligher
C Peacock
R Rahim
K Satchithananda
M Michell
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr3701

Other articles of this Special Issue 1/2014

Breast Cancer Research 1/2014 Go to the issue

Poster presentation

PB.30. Apparent diffusion coefficient and fractional anisotropy values as biomarkers for treatment response in breast cancer

Poster presentation

PB.25. Implementation of two new digital mammography technologies for Breast Test Wales: more or less accurate?

Poster presentation

PB.21. Is the technical quality of screening mammograms lower in Asian women who cannot understand the English language?

Poster presentation

PB.13. Impact on film reading of moving from analogue to digital screening: a service evaluation - South East Scotland Breast Screening Programme

Poster presentation

PB.32. Type of breast surgery in patients undergoing neoadjuvant chemotherapy: role of DCE-MRI

Poster presentation

PB.7. Large-volume biopsy for B3 lesions without atypia: is once enough?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits